Article
Genotyping and phenotyping the cytochrome p-450 enzymes.
American journal of therapeutics - 1 Jan 2000
Bachmann Kenneth A
Abstract excerpt
With estimates of the percentage of pharmaceuticals that are subject to metabolism by the cytochrome P-450 enzymes (CYPs) in excess of 80%, the relative activities of these enzymes in various subpopulations and even in individual patients can have important ramifications in matters ranging from dose selection to prediction of toxicity to suitability of a new chemical entity (NCE) for continued drug development....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
